Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.

Suppr

超能文献

作者信息

Valenta L J, Sigel M B, Lesniak M A, Elias A N, Lewis U J, Friesen H G, Kershnar A K

出版信息

N Engl J Med. 1985 Jan 24;312(4):214-7. doi: 10.1056/NEJM198501243120405.

DOI:10.1056/NEJM198501243120405

PMID:3965948

Abstract

摘要

相似文献

Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers.

N Engl J Med. 1985 Jan 24;312(4):214-7. doi: 10.1056/NEJM198501243120405.

[Somatomedin following administration of growth hormone in pituitary dwarfism].

Cesk Pediatr. 1978 Oct;33(10):582-6.

Radioimmunoassayable serum somatomedin B in normal subjects and in patients with acromegaly and pituitary dwarfism: effects of human growth hormone therapy.

Horm Metab Res. 1980 Oct;12(10):516-9. doi: 10.1055/s-2007-999189.

Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.垂体性侏儒症患者生长激素治疗后生长调节素反应的稳定性及其与生长速率的无关性。

J Clin Endocrinol Metab. 1981 Sep;53(3):611-7. doi: 10.1210/jcem-53-3-611.

[Growth disorders in childhood].

Fortschr Med. 1972 Sep 28;90(27):961-6.

Abnormal growth hormone and dwarfism.生长激素异常与侏儒症。

N Engl J Med. 1985 Jul 25;313(4):268-9. doi: 10.1056/NEJM198507253130418.

Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.垂体性侏儒症患者长期接受人生长激素治疗期间血清生长调节素A水平与生长情况

Acta Endocrinol (Copenh). 1979 Nov;92(3):385-97. doi: 10.1530/acta.0.0920385.

Human somatomedin. Determination, occurrence, biological activity and purification.

Acta Endocrinol Suppl (Copenh). 1972;163:1052.

[Behavior of the somatotropic hormone and of somatomedin (sulfation factor) in achondroplasia].[生长激素及生长调节素（硫酸化因子）在软骨发育不全中的表现]

Folia Endocrinol. 1974 Apr;27(2):179-84.

[The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].

Arch Fr Pediatr. 1973 Jun-Jul;30(6):595-608.

引用本文的文献

Efficacy of long-term growth hormone therapy in short children with reduced growth hormone biological activity.长期生长激素治疗对生长激素生物活性降低的矮小儿童的疗效。

J Endocrinol Invest. 2011 May;34(5):366-9. doi: 10.1007/BF03347461. Epub 2011 Apr 20.

Severe short stature and endogenous growth hormone resistance in twin brothers without growth hormone gene mutations.

Endocrine. 2003 Aug;21(3):289-95. doi: 10.1385/ENDO:21:3:289.

Molecular heterogeneity of human GH: from basic research to clinical implications.人生长激素的分子异质性：从基础研究到临床意义

J Endocrinol Invest. 2003 Mar;26(3):274-88. doi: 10.1007/BF03345170.

Biologically inactive growth hormone caused by an amino acid substitution.由氨基酸替代导致的无生物活性的生长激素。

J Clin Invest. 1997 Sep 1;100(5):1159-65. doi: 10.1172/JCI119627.

Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome.唐氏综合征中生长激素-胰岛素样生长因子-I轴的评估

J Endocrinol Invest. 1994 Jun;17(6):431-6. doi: 10.1007/BF03347731.

Identification and characterization of specific binding proteins for growth hormone in normal human sera.正常人血清中生长激素特异性结合蛋白的鉴定与特性分析

J Clin Invest. 1986 Jun;77(6):1817-23. doi: 10.1172/JCI112507.

Growth hormone therapy in Canada: end of one era and beginning of another.加拿大的生长激素疗法：一个时代的结束与另一个时代的开始。

CMAJ. 1986 Aug 15;135(4):297-301.

Short stature--physiology and pathology.身材矮小——生理学与病理学

West J Med. 1986 Jun;144(6):710-21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验